MENU
GLMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Galmed Pharmaceuticals (GLMD) Earnings Date & Reports

A.I. Advisor
published Earnings

GLMD is expected to report earnings to rise 18.52% to -31 cents per share on March 14

Galmed Pharmaceuticals GLMD Stock Earnings Reports
Q4'23
Est.
$-0.32
Q3'23
Beat
by $0.03
Q2'23
Est.
$-0.34
Q1'23
Beat
by $0.41
Q4'22
Missed
by $1.36
The last earnings report on November 06 showed earnings per share of -27 cents, beating the estimate of -30 cents. With 17.59K shares outstanding, the current market capitalization sits at 4.67M.
View a ticker or compare two or three
GLMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
16 Tiomkin Street
Phone
+972 36938448
Employees
10
Web
https://www.galmedpharma.com